Intrapleural Ropivacaine Infusion in Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 116 participants.

Also called NCT07116343

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 116 participants (planned count) (from the registry)
Sponsor
Saint Petersburg State University, Russia (from the registry)
Registry
  • NCT NCT07116343
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07116343. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-22 (actual); primary completion 2027-09-25 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intrapleural Ropivacaine Infusion in Cardiac Surgery
Acronym
IRICS
Condition
Cardiac Surgery
Condition
Valvular Diseases
Intervention (Drug)
Ropivacaine
Intervention (Drug)
0.9 % NaCl
Lead sponsor
Saint Petersburg State University, Russia (class: other)
Collaborator
Primorsky Regional Clinical Hospital No. 1 (class: not stated)

Record details

Record id
cardio:ct-nct07116343
Content hash
24f83c0b025505a13bec7928d690d4c0ed4130f8e8a9e2196883fa0ced904386